<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The optimal methods for <z:chebi fb="105" ids="17234">glucose</z:chebi> control and reduction in the risk of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> are controversial </plain></SENT>
<SENT sid="1" pm="."><plain>Findings from recent clinical trials have shown different viewpoints on the advantages and disadvantages of intensive lowering of <z:chebi fb="105" ids="17234">glucose</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>We used echocardiography to explore the influence of the <z:chebi fb="105" ids="17234">glucose</z:chebi>-lowering rate on left ventricular function in patients with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (T2DM) </plain></SENT>
<SENT sid="3" pm="."><plain>We also attempted to discover an effective <z:chebi fb="105" ids="17234">glucose</z:chebi>-lowering rate for patients with type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> and <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e> (T2DM-CHD) </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: A total of 132 cases of T2DM and 135 cases of T2DM-CHD received intensive <z:chebi fb="105" ids="17234">glucose</z:chebi> therapy </plain></SENT>
<SENT sid="5" pm="."><plain>After measuring left ventricular ejection fraction (LVEF) and the E/A ratio, variations and correlation factors were evaluated </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: LVEF was significantly higher than before intensive therapy in the T2DM group with a <z:chebi fb="105" ids="17234">glucose</z:chebi>-lowering rate of ≤6mmol·L(-1)·d(-1) (P&lt;.05) </plain></SENT>
<SENT sid="7" pm="."><plain>LVEF was significantly lower than before intensive therapy in the T2DM-CHD group with a <z:chebi fb="105" ids="17234">glucose</z:chebi>-lowering rate &gt;4mmol·L(-1)·d(-1) (P&lt;.05), whereas at the end of follow-up (3months), LVEF increased and no significant difference was observed between subgroups (P&gt;.05) </plain></SENT>
<SENT sid="8" pm="."><plain>The E/A ratio increased among <z:hpo ids='HP_0000001'>all</z:hpo> subgroups after intensive therapy (P&lt;.05) </plain></SENT>
<SENT sid="9" pm="."><plain>The waist-hip ratio, duration of T2DM, and age had a linear regression relationship with variations in LVEF before and after intensive therapy </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: For patients with T2DM and CHD, an excessively fast <z:chebi fb="105" ids="17234">glucose</z:chebi>-lowering rate could impair left ventricular systolic function </plain></SENT>
<SENT sid="11" pm="."><plain>Long-term, good control of blood <z:chebi fb="105" ids="17234">glucose</z:chebi> could restore the impaired left ventricular systolic function caused by an excessively fast <z:chebi fb="105" ids="17234">glucose</z:chebi>-lowering rate </plain></SENT>
<SENT sid="12" pm="."><plain>After intensive therapy, left ventricular diastolic function improved among <z:hpo ids='HP_0000001'>all</z:hpo> subgroups regardless of the <z:chebi fb="105" ids="17234">glucose</z:chebi>-lowering rate and CHD </plain></SENT>
</text></document>